Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMIX Autonomix Medical	$1.12 +1.8%	$1.33	$0.96 ▼ $21.49	$6.63M	-2.96	619,561 shs	251,857 shs
GCTK GlucoTrack	$4.22 -1.9%	$6.07	$4.22 ▼ $3,756.00	$3.80M	-0.19	404,961 shs	16,159 shs
NAOV Nanovibronix	$5.46 -2.0%	$8.33	$5.00 ▼ $162.50	$1.42M	1.83	291,315 shs	17,335 shs
NUWE Nuwellis	$5.10 -1.5%	$8.63	$4.82 ▼ $175.98	$4.59M	N/A	404,754 shs	21,971 shs

Reduce the Risk

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMIX Autonomix Medical	-6.78%	+8.91%	-13.39%	-31.25%	-90.44%
GCTK GlucoTrack	-3.15%	-21.10%	-34.55%	-43.12%	-99.87%
NAOV Nanovibronix	-4.30%	+10.74%	-34.08%	-50.27%	-91.18%
NUWE Nuwellis	+0.58%	-2.08%	-50.76%	-85.85%	-90.36%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AMIX Autonomix Medical	2.8031 of 5 stars	3.5	2.0	2.5	1.7	1.3
GCTK GlucoTrack	0.4948 of 5 stars	0.0	2.0	2.7	0.8	0.6
NAOV Nanovibronix	0.6804 of 5 stars	0.0	3.0	3.3	0.0	0.6
NUWE Nuwellis	0.8981 of 5 stars	0.0	4.0	1.5	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMIX Autonomix Medical	3.00	Buy	$16.50	1,373.21% Upside
GCTK GlucoTrack	0.00	N/A	N/A	N/A
NAOV Nanovibronix	0.00	N/A	N/A	N/A
NUWE Nuwellis	3.00	Buy	N/A	N/A

Current Analyst Ratings Breakdown

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMIX Autonomix Medical	N/A	N/A	N/A	N/A	$1.19 per share	N/A
GCTK GlucoTrack	N/A	N/A	N/A	N/A	$7.65 per share	N/A
NAOV Nanovibronix	$2.56M	0.55	N/A	N/A	$156.59 per share	0.03
NUWE Nuwellis	$8.74M	0.53	N/A	N/A	($9.93) per share	-0.51

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMIX Autonomix Medical	-$11.41M	-$5.74	N/A	N/A	N/A	N/A	-172.93%	-133.39%	11/14/2025 (Estimated)
GCTK GlucoTrack	-$22.60M	-$56.60	N/A	∞	N/A	N/A	N/A	-352.05%	N/A
NAOV Nanovibronix	-$3.70M	-$13.53	N/A	∞	N/A	-380.29%	-45.24%	-34.24%	11/12/2025 (Estimated)
NUWE Nuwellis	-$11.16M	-$35.36	N/A	N/A	N/A	-176.45%	-1,424.01%	-187.69%	11/10/2025 (Estimated)

Latest NAOV, AMIX, GCTK, and NUWE Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/19/2025	Q2 2025	NAOV Nanovibronix	N/A	-$1.03	N/A	-$1.03	N/A	$0.49 million
8/14/2025	Q2 2025	GCTK GlucoTrack	N/A	-$9.62	N/A	-$9.62	N/A	N/A
8/13/2025	Q1 2026	AMIX Autonomix Medical	-$0.98	-$1.07	-$0.09	-$1.07	N/A	N/A
8/12/2025	Q2 2025	NUWE Nuwellis	-$0.45	-$60.99	-$60.54	-$60.99	$2.20 million	$1.73 million
5/29/2025	Q4 2025	AMIX Autonomix Medical	N/A	-$0.74	N/A	-$0.74	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMIX Autonomix Medical	N/A	N/A	N/A	N/A	N/A
GCTK GlucoTrack	N/A	N/A	N/A	N/A	N/A
NAOV Nanovibronix	N/A	N/A	N/A	N/A	N/A
NUWE Nuwellis	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMIX Autonomix Medical	N/A	4.57	4.57
GCTK GlucoTrack	0.03	3.27	3.27
NAOV Nanovibronix	N/A	1.05	0.72
NUWE Nuwellis	N/A	2.16	1.64

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMIX Autonomix Medical	10.78%
GCTK GlucoTrack	10.92%
NAOV Nanovibronix	16.39%
NUWE Nuwellis	3.13%

Insider Ownership

Company	Insider Ownership
AMIX Autonomix Medical	32.40%
GCTK GlucoTrack	12.91%
NAOV Nanovibronix	6.30%
NUWE Nuwellis	20.08%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMIX Autonomix Medical	1	5.92 million	4.00 million	N/A
GCTK GlucoTrack	5	900,000	783,000	Not Optionable
NAOV Nanovibronix	20	260,000	242,000	Not Optionable
NUWE Nuwellis	70	900,000	722,000	Not Optionable

NAOV, AMIX, GCTK, and NUWE Headlines

Recent News About These Companies

Nuwellis receives FDA 510k clearance for new dELC

August 22, 2025 | msn.com

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

August 21, 2025 | globenewswire.com

Nuwellis, Inc.: Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

August 19, 2025 | finanznachrichten.de

Nuwellis signs LOI to explore acquisition of Rendiatech

August 19, 2025 | msn.com

Nuwellis signs letter of intent to acquire Rendiatech

August 19, 2025 | msn.com

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

August 19, 2025 | globenewswire.com

Nuwellis, Inc. Reports Q2 2025 Financial Results

August 15, 2025 | msn.com

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

August 15, 2025 | globenewswire.com

Nuwellis outlines Q3 recovery and strategic shift after resolving $400,000 back order

August 14, 2025 | msn.com

Nuwellis, Inc. (NUWE) Q2 2025 Earnings Call Transcript

August 14, 2025 | seekingalpha.com

Nuwellis reports Q2 EPS ($60.99) vs ($791.82) last year

August 14, 2025 | msn.com

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

August 14, 2025 | globenewswire.com

An Overview of Nuwellis's Earnings

August 13, 2025 | benzinga.com

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus

August 7, 2025 | globenewswire.com

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

August 6, 2025 | globenewswire.com

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code

August 5, 2025 | globenewswire.com

Nuwellis Stockholders Approve All Proposals at Special Meeting

August 4, 2025 | globenewswire.com

Nuwellis, Inc. (NUWE) - Yahoo Finance

July 30, 2025 | finance.yahoo.com

Nuwellis Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

July 23, 2025 | finance.yahoo.com

Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

July 23, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

NAOV, AMIX, GCTK, and NUWE Company Descriptions

Autonomix Medical NASDAQ:AMIX

$1.12 +0.02 (+1.82%)

Closing price 04:00 PM Eastern

Extended Trading

$1.10 -0.02 (-1.43%)

As of 06:07 PM Eastern

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

GlucoTrack NASDAQ:GCTK

$4.22 -0.08 (-1.86%)

Closing price 04:00 PM Eastern

Extended Trading

$4.30 +0.08 (+1.90%)

As of 06:18 PM Eastern

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

Nanovibronix NASDAQ:NAOV

$5.46 -0.11 (-1.97%)

Closing price 04:00 PM Eastern

Extended Trading

$5.64 +0.19 (+3.39%)

As of 05:36 PM Eastern

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.

Nuwellis NASDAQ:NUWE

$5.10 -0.08 (-1.54%)

Closing price 04:00 PM Eastern

Extended Trading

$5.11 +0.01 (+0.10%)

As of 05:37 PM Eastern

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time